Identification of the Pathogenetic Mechanisms Underlying Squamous Cell Carcinomas

Recruiting now

Conditions studied: Squamous Cell Carcinoma of the Head and Neck, Squamous Cell Carcinoma of the Anus

In brief

This is a multicentric, retrospective, and prospective biomarker study.

Key facts

Study ID

NCT06236464

Run by

National Cancer Institute, Naples

People needed

170

Starts

2023-09-25

Expected to finish

2026-03-01

Last updated by the study team

2025-07-29

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Patients aged ≥ 18 years, candidates for surgical treatment for squamous cell carcinoma of the anus, uterine cervix, vulva, and head-neck region (including microinvasive and invasive carcinomas) who are capable of understanding and willing to sign the informed consent form. Prospective patients must provide written informed consent before any procedures.

You may not qualify if…

• Patients presenting any of the following criteria are not eligible for inclusion in this study. Exclusion criteria include:
• Metastatic neoplasia
• Treatment for other oncological pathologies
• Congenital or acquired immunosuppression (HIV, organ transplant, pharmacological)

Where it is running

• Istituto Tumori IRCCS Giovanni Paolo II di Bari — Bari, Bari, Italy (enrolling)
• Istituto Nazionale Tumori | "Fondazione Pascale" — Naples, Napoli, Italy (enrolling)
• Università del Piemonte orientale — Novara, Novara, Italy (enrolling)
• Azienda Ospedaliera Universitaria Pisana — Pisa, Pisa, Italy (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.